What Is Fresenius Medical Care AG's (ETR:FME) Share Price Doing?
Nov 21
Have your own idea? Try our Stock Screener
German (DAX) Healthcare Sector Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies58
- 7D-3.7%
- 3M-11.1%
- 1Y-13.7%
- YTD-14.7%
Over the last 7 days, the Healthcare industry has dropped 3.7%, driven by Merck KGaA declining 8.9%. In contrast, Dermapharm Holding has gained 18%. Overall the industry is down 14% in 12 months. As for the next few years, earnings are expected to grow by 22% per annum.
Sector Valuation and Performance
Has the German Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | €205.5b | €159.2b | €5.0b | 21.6x | 41x | 1.3x |
| Sat, 19 Oct 2024 | €231.4b | €159.3b | €5.7b | 21.6x | 40.7x | 1.5x |
| Mon, 16 Sep 2024 | €229.6b | €159.2b | €5.6b | 22.4x | 41x | 1.4x |
| Wed, 14 Aug 2024 | €225.7b | €159.1b | €5.6b | 25.3x | 40.1x | 1.4x |
| Fri, 12 Jul 2024 | €227.9b | €158.6b | €3.5b | 24.5x | 64.4x | 1.4x |
| Sun, 09 Jun 2024 | €240.7b | €158.6b | €3.5b | 26.9x | 68.2x | 1.5x |
| Tue, 07 May 2024 | €232.0b | €159.0b | €3.5b | 25.1x | 66.7x | 1.5x |
| Thu, 04 Apr 2024 | €244.2b | €159.4b | €3.2b | 25.3x | 76.3x | 1.5x |
| Sat, 02 Mar 2024 | €243.9b | €178.9b | €3.3b | 21.2x | 72.9x | 1.4x |
| Mon, 29 Jan 2024 | €245.3b | €188.4b | €3.3b | 22.3x | 74.5x | 1.3x |
| Wed, 27 Dec 2023 | €243.0b | €188.4b | €3.3b | 21.8x | 74.3x | 1.3x |
| Fri, 24 Nov 2023 | €243.3b | €188.4b | €3.3b | 23.1x | 74.1x | 1.3x |
| Sun, 22 Oct 2023 | €234.7b | €189.3b | €8.6b | 21.4x | 27.2x | 1.2x |
| Tue, 19 Sep 2023 | €254.9b | €189.5b | €8.8b | 22.4x | 29.1x | 1.3x |
| Thu, 17 Aug 2023 | €263.5b | €189.4b | €8.9b | 24.6x | 29.7x | 1.4x |
| Sat, 15 Jul 2023 | €260.0b | €191.1b | €10.5b | 24x | 24.7x | 1.4x |
| Mon, 12 Jun 2023 | €270.4b | €191.1b | €10.5b | 23.4x | 25.8x | 1.4x |
| Wed, 10 May 2023 | €279.9b | €190.7b | €12.5b | 23.1x | 22.4x | 1.5x |
| Fri, 07 Apr 2023 | €287.8b | €190.5b | €12.6b | 22.4x | 22.8x | 1.5x |
| Sun, 05 Mar 2023 | €279.9b | €189.6b | €13.2b | 18.1x | 21.2x | 1.5x |
| Tue, 31 Jan 2023 | €288.1b | €187.6b | €13.9b | 18.2x | 20.8x | 1.5x |
| Thu, 29 Dec 2022 | €262.9b | €187.5b | €13.9b | 21.3x | 18.9x | 1.4x |
| Sat, 26 Nov 2022 | €277.6b | €187.4b | €13.9b | 21.4x | 20x | 1.5x |
| Mon, 24 Oct 2022 | €246.8b | €182.4b | €13.4b | 20x | 18.4x | 1.4x |
| Wed, 21 Sep 2022 | €231.1b | €178.6b | €12.9b | 18.7x | 17.9x | 1.3x |
| Fri, 19 Aug 2022 | €284.7b | €182.3b | €13.4b | 18.3x | 21.2x | 1.6x |
| Sun, 17 Jul 2022 | €281.7b | €178.5b | €11.3b | 23.8x | 24.9x | 1.6x |
| Tue, 14 Jun 2022 | €287.2b | €185.9b | €11.4b | 23.2x | 25.2x | 1.5x |
| Thu, 12 May 2022 | €287.0b | €184.9b | €11.3b | 21.3x | 25.3x | 1.6x |
| Sat, 09 Apr 2022 | €321.1b | €179.8b | €10.0b | 25.3x | 32x | 1.8x |
| Mon, 07 Mar 2022 | €288.8b | €178.3b | €9.6b | 21.5x | 29.9x | 1.6x |
| Wed, 02 Feb 2022 | €325.6b | €175.4b | €9.3b | 26.2x | 35.2x | 1.9x |
| Fri, 31 Dec 2021 | €353.1b | €175.4b | €9.3b | 29.8x | 38.1x | 2x |
| Sun, 28 Nov 2021 | €343.8b | €158.6b | €9.3b | 28.7x | 37.1x | 2.2x |
Price to Earnings Ratio
37.1x
Current Industry PE
- Investors are relatively neutral on the German Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 38.1x.
- The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 18% per year over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the German Healthcare sector?
| DE Market | -0.41% | |
| Healthcare | -3.73% | |
| Biotech | 0.75% | |
| Healthcare Services | -0.34% | |
| Medical Equipment | -0.40% | |
| Healthtech | -1.28% | |
| Life Sciences | -6.39% | |
| Pharma | -6.98% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 63.4x.
- Analysts are expecting annual earnings growth of 34.0%, which is higher than its past year's earnings growth of 5.4% per year.
- Investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 34.4x.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 58% over the next 5 years.
- This is better than its past earnings decline of 66% per year.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DMP Dermapharm Holding | €36.90 | 17.9% +€301.5m | -8.2% | PE21.9x | |
| EVT Evotec | €9.91 | 15.6% +€237.6m | -48.3% | PS2.3x | |
| FME Fresenius Medical Care | €40.80 | 2.0% +€231.8m | 12.7% | PE18.2x | |
| PHH2 Paul Hartmann | €212.00 | 7.6% +€53.3m | 6.3% | PE12.6x | |
| M12 M1 Kliniken | €17.20 | 4.6% +€13.9m | 90.3% | PE19x |
